Episode Summary
Haven, the joint venture between Amazon, JPMorgan Chase and Berkshire Hathaway, is making its first move as a disrupter in the health care space by offering health plans to 30,000 JPMorgan employees in Ohio and Arizona. In this week’s Our Take read-in, John discusses the move, along with what’s happening with Google.
Episode Notes
Other briefs include:
- Stryker signed a definitive agreement to acquire Wright Medical Group.
- Amgen will pay $2.7 billion for a 20.5% ownership stake in BeiGene, a research-based, oncology-focused biotech company headquartered in Beijing.
- The University of Louisville announced that it has completed the acquisition of KentuckyOne Health’s Louisville-area assets from CommonSpirit Health.
- HealthPartners is closing its mail order and all 30 retail pharmacy locations, and will lay off 300 workers.
- Dr. Philip Ozuah will become Montefiore Medicine’s new CEO.
- Dr. Stephen Hahn has been nominated as the FDA’s new commissioner.
- Several updates from CMS.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media
Recommended Next
Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes
Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports
Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations
Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.
